Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis

PLoS ONE(2025)10.1371/journal.pone.0309191Source: DataRank Database

Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis is a research paper published in PLoS ONE (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: goldTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Emily Armantrout,Katie R. Poch,Silvia M. Caceres ORCID,Valerie K. Lovell,Marion C. Jones

Live enrichment

PubMed:40063876 PMC:PMC11893114 OpenAlex:https://openalex.org/W4408289051

Cystic Fibrosis Foundation

Grant: NICK17K0

Cystic Fibrosis Foundation

Grant: NICK18P0

Cystic Fibrosis Foundation

Grant: NICK20Y2-SVC

Cystic Fibrosis Foundation

Grant: NICK20Y2-OUT

Cystic Fibrosis Foundation

Grant: NICK23A1

National Institutes of Health

Grant: R01HL146228

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0309191&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0309191&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0309191

journalhttps://doi.org/10.1371/journal.pone.0309191

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40063876

Fields of Study

Mycobacterium research and diagnosisCystic Fibrosis Research AdvancesTuberculosis Research and EpidemiologyHumansCystic FibrosisLipopolysaccharidesSputumProspective StudiesBiomarkersAdultMycobacterium Infections, NontuberculousMaleFemaleNontuberculous Mycobacteria

MeSH Terms

AdultCystic FibrosisFemaleHumansLipopolysaccharidesMaleMycobacterium Infections, NontuberculousNontuberculous MycobacteriaProspective StudiesSputumBiomarkers

Keywords

SputumMedicineLipoarabinomannanSputum cultureInternal medicineUrineNontuberculous mycobacteriaSurrogate endpointClinical endpointPopulationProspective cohort studyRandomized controlled trialImmunologyIntensive care medicineTuberculosisPathologyMycobacterium tuberculosisMycobacterium

Sustainable Development Goals

SDG 0: Good health and well-being

Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis

FAIR Checklist

Authors (14)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)